<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bmjour</journal-id><journal-title-group><journal-title xml:lang="ru">Байкальский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Baikal Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-0715</issn><publisher><publisher-name>Irkutsk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.57256/2949-0715-2026-5-1-61-71</article-id><article-id custom-type="elpub" pub-id-type="custom">bmjour-345</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>ПОЛИМОРФИЗМ ГЕНА N-АЦЕТИЛТРАНСФЕРАЗЫ 2 У БОЛЬНЫХ С ЭУТИРЕОИДНЫМ И ТОКСИЧЕСКИМ ЗОБОМ В ИРКУТСКОЙ ОБЛАСТИ</article-title><trans-title-group xml:lang="en"><trans-title>N-ACETYLTRANSFERASE 2 GENE POLYMORPHISM IN PATIENTS WITH EUTHYROID AND TOXIC GOITER IN THE IRKUTSK REGION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2081-8665</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильичева</surname><given-names>Елена Алексеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Ilyicheva</surname><given-names>Elena A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующая научным отделом клинической хирургии;</p><p>врач-хирург хирургического торакального отделения</p></bio><bio xml:lang="en"><p>Dr. Sc. (Med.), Professor, Head of the Research Department of Clinical Surgery;</p><p>surgeon of the surgical thoracic department</p></bio><email xlink:type="simple">lena_isi@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5080-9225</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родионова</surname><given-names>Любовь Викторовна</given-names></name><name name-style="western" xml:lang="en"><surname>Rodionova</surname><given-names>Lyubov V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., заведующая лабораторией клеточной патофизиологии и биохимии</p></bio><bio xml:lang="en"><p>Cand.  Sc. (Biol.), Head of the Laboratory of Cell Pathophysiology and Biochemistry</p></bio><email xlink:type="simple">greidmacho@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4482-6130</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самойлова</surname><given-names>Лилия Григорьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Samoilova</surname><given-names>Liliya G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории клеточной патофизиологии и биохимии</p></bio><bio xml:lang="en"><p>Junior Research Officer at the Laboratory of Cell Pathophysiology and Biochemistry</p></bio><email xlink:type="simple">popovalg@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3273-774X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рой</surname><given-names>Татьяна Аркадьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Roy</surname><given-names>Tatiana A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник научного отдела клинической хирургии</p></bio><bio xml:lang="en"><p>Junior Research Officer at the Research Department of Clinical Surgery</p></bio><email xlink:type="simple">t_roy@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6887-8325</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берсенев</surname><given-names>Глеб Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Bersenev</surname><given-names>Gleb A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., ассистент кафедры госпитальной хирургии;</p><p>врач-хирург отделения портальной гипертензии</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), assistant, department of Hospital Surgery;</p><p>surgeon, department of portal hypertension</p></bio><email xlink:type="simple">glbersenev17@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутский научный центр хирургии и травматологии;&#13;
Иркутская ордена «Знак почета» областная клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk Scientific Center of Surgery and Traumatology;&#13;
Irkutsk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Иркутский научный центр хирургии и травматологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk Scientific Center of Surgery and Traumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Иркутский государственный медицинский университет;&#13;
Иркутская ордена «Знак почета» областная клиническая больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University;&#13;
Irkutsk Regional Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2026</year></pub-date><volume>5</volume><issue>1</issue><fpage>61</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ильичева Е.А., Родионова Л.В., Самойлова Л.Г., Рой Т.А., Берсенев Г.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ильичева Е.А., Родионова Л.В., Самойлова Л.Г., Рой Т.А., Берсенев Г.А.</copyright-holder><copyright-holder xml:lang="en">Ilyicheva E., Rodionova L., Samoilova L., Roy T., Bersenev G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bmjour.ru/jour/article/view/345">https://www.bmjour.ru/jour/article/view/345</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. N-ацетилтрансфераза 2 – фермент, участвующий в детоксикации ксенобиотиков. Её ген – полиморфный и определяет восприимчивость к неоплазиям, метаболическим изменениям и заболеваниям.</p></sec><sec><title>Цель</title><p>Цель. Изучить особенности полиморфизма гена N-ацетилтрансферазы 2  в образцах крови у больных, оперированных по поводу эутиреоидного и токсического зоба, и его роль в развитии осложнений заболевания и операции.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены пациенты, проживающие на территории Иркутской области, которые прооперированы в объеме тиреоидэктомии по поводу доброкачественных заболеваний щитовидной железы: 12 с диффузным токсическим зобом , 9 с многоузловым токсическим зобом и 11 с многоузловым эутиреоидным зобом. Изучались однонуклеотидные полиморфизмы в структурной области гена N-ацетилтрансферазы 2 (С282Т (rs1041983), T341C (rs1801280), С481Т (rs1799929), G590A (rs1799930), А803G (rs1208) и G857A (rs1799931)) методом полимеразной цепной реакции. </p></sec><sec><title>Результаты</title><p>Результаты. При токсических формах зоба частота выявления неизменной последовательности нуклеотидов в позиции C282T снижена (до 45 % и 50 % соответственно), в сравнении с группой контроля (p &lt;0,0005). Частота выявления полиморфизма Т341С в гомозиготном состоянии при многоузловом токсическом зобе составила 33 % и не выявлялась при диффузном токсическом зобе и в контроле (p &lt;0,0005). Частота развития нейтропении на фоне приема тиамазола составила 9 % и не зависела от полиморфизма С282Т (p&gt;0,95). Установлена статистически значимая сопряженность между частотой выявления дикого и мутантного типа по всем исследованным нуклеотидным цепям гена N-ацетилтрансферазы 2, кроме G857A. При диффузном токсическом зобе отмечалась умеренная отрицательная корреляция между C282T и C481T, Т341С (p &lt;0,0005). В тоже время при многоузловом токсическом зобе выявлена положительная связь между C282T и G590A (p &lt;0,0005).</p></sec><sec><title>Заключение</title><p>Заключение. Исследование демонстрирует особенности полиморфизма гена N-ацетилтрансферазы 2 в образцах крови у больных, оперированных по поводу эутиреоидного и токсического зоба.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. N-acetyltransferase 2 is an enzyme involved in the detoxification of xenobiotics. The N-acetyltransferase 2 gene is polymorphic and causes variants of the enzyme structure, determining susceptibility to neoplasia, metabolic changes and diseases.</p></sec><sec><title>The aim</title><p>The aim. To study the features of the N-acetyltransferase 2 gene polymorphism in blood samples of patients operated on for euthyroid and toxic goiter, and its role in the development of complications of the disease and surgery.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included patients living in the Irkutsk region who, during 2021–2023, underwent thyroidectomy for euthyroid and toxic goiter: 11 patients with diffuse toxic goiter, 12 with multinodular toxic goiter and 18 with multinodular euthyroid goiter. The control group is volunteers without thyroid pathology. Single nucleotide polymorphisms in the structural region of the N-acetyltransferase 2 gene (С282Т (rs1041983), T341C (rs1801280), С481Т (rs1799929), G590A (rs1799930), А803G (rs1208) и G857A (rs1799931)) were studied by the polymerase chain reaction method.</p></sec><sec><title>Results</title><p>Results. The frequency of detection of the unchanged nucleotide sequence at position C282T is reduced (up to 45 % in diffuse toxic goiter and 50 % in multinodular toxic goiter) (p &lt;0.0005). The frequency of detection of the T341C polymorphism in the homozygous state in multinodular toxic goiter was 33 % and was not detected in diffuse toxic goiter and in the control (p &lt;0.0005). The frequency of neutropenia development against the background of thiamazole intake was 9 % and did not depend on the C282T polymorphism (p&gt;0.95). In diffuse toxic goiter, a moderate negative correlation was noted between C282T and C481T, T341C (p &lt;0.0005). At the same time, in multinodular toxic goiter, a positive relationship was found between C282T and G590A (p &lt;0.0005).  </p></sec><sec><title>Conclusion</title><p>Conclusion. The study demonstrates the features of the N-acetyltransferase 2 gene polymorphism in blood samples of patients operated on for euthyroid and toxic goiter</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ген N-ацетилтрансферазы 2</kwd><kwd>полиморфизм гена N-ацетилтрансферазы 2</kwd><kwd>доброкачественные заболевания щитовидной железы</kwd><kwd>многоузловой зоб</kwd><kwd>диффузный токсический зоб</kwd></kwd-group><kwd-group xml:lang="en"><kwd>N-acetyltransferase 2 gene</kwd><kwd>N-acetyltransferase 2 gene polymorphism</kwd><kwd>benign thyroid diseases</kwd><kwd>multinodular goiter</kwd><kwd>diffuse toxic goiter</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hein D.W., Millner L.M. Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. Expert Opin Drug Metab Toxicol. 2021;17(1):9-21. https://doi.org/10.1080/17425255.2021.1840551</mixed-citation><mixed-citation xml:lang="en">Hein D.W., Millner L.M. Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. Expert Opin Drug Metab Toxicol. 2021;17(1):9-21. https://doi.org/10.1080/17425255.2021.1840551</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Тийс Р.П., Осипова Л.П., Галиева Э.Р. и др. Полиморфизм вариантов гена N-ацетилтрансферазы 2 (NAT2) и анализ генной сети. Биомедицинская химия. 2021;67(3):213-221 [Tiis R.P., Osipova L.P., Galieva E.R. et al. Polymorphism of N-acetyltransferase 2 (NAT2) gene variants and gene network analysis. Biomedical Chemistry. 2021;67(3):213–221 (In Russ.)]. https://doi.org/10.18097/PBMC20216703213</mixed-citation><mixed-citation xml:lang="en">Тийс Р.П., Осипова Л.П., Галиева Э.Р. и др. Полиморфизм вариантов гена N-ацетилтрансферазы 2 (NAT2) и анализ генной сети. Биомедицинская химия. 2021;67(3):213-221 [Tiis R.P., Osipova L.P., Galieva E.R. et al. Polymorphism of N-acetyltransferase 2 (NAT2) gene variants and gene network analysis. Biomedical Chemistry. 2021;67(3):213–221 (In Russ.)]. https://doi.org/10.18097/PBMC20216703213</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Salazar-González R.A., Doll M.A., Hein D.W. N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. Archives of Toxicology. 2023;97(1):189-199. https://doi.org/10.1007/s00204-022-03383-2</mixed-citation><mixed-citation xml:lang="en">Salazar-González R.A., Doll M.A., Hein D.W. N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. Archives of Toxicology. 2023;97(1):189-199. https://doi.org/10.1007/s00204-022-03383-2</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">McDonagh E.M., Boukouvala S., Aklillu E. et al. PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics. 2014;24(8):409-25. https://doi.org/10.1097/FPC.0000000000000062</mixed-citation><mixed-citation xml:lang="en">McDonagh E.M., Boukouvala S., Aklillu E. et al. PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics. 2014;24(8):409-25. https://doi.org/10.1097/FPC.0000000000000062</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Habil M.R., Salazar-González R.A., Doll M.A. et al. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes. Archives of Toxicology. 2022;96(12):3257-3263. https://doi.org/10.1007/s00204-022-03381-4</mixed-citation><mixed-citation xml:lang="en">Habil M.R., Salazar-González R.A., Doll M.A. et al. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes. Archives of Toxicology. 2022;96(12):3257-3263. https://doi.org/10.1007/s00204-022-03381-4</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gutiérrez-Virgen J.E., Piña-Pozas M., Hernández-Tobías E.A. et al. NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review. PLoS One. 2023;18(4): e0283726. https://doi.org/10.1371/journal.pone.0283726</mixed-citation><mixed-citation xml:lang="en">Gutiérrez-Virgen J.E., Piña-Pozas M., Hernández-Tobías E.A. et al. NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review. PLoS One. 2023;18(4): e0283726. https://doi.org/10.1371/journal.pone.0283726</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hong K.U., Hein D.W. N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer. Pharmacogenetics Genomics. 2023;33(6):136-137. https://doi.org/10.1097/FPC.0000000000000500</mixed-citation><mixed-citation xml:lang="en">Hong K.U., Hein D.W. N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer. Pharmacogenetics Genomics. 2023;33(6):136-137. https://doi.org/10.1097/FPC.0000000000000500</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huang B.Z., Wang S., Bogumil D. et al. Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. Int J Cancer. Published online April 12, 2021. https://doi.org/10.1002/ijc.33598</mixed-citation><mixed-citation xml:lang="en">Huang B.Z., Wang S., Bogumil D. et al. Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. Int J Cancer. Published online April 12, 2021. https://doi.org/10.1002/ijc.33598</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mohamed Noor N.F., Salleh M.Z., Mohd Zim M.A. et al. NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity. Pharmacogenomics. 2022;23(9):531-541. https://doi.org/10.2217/pgs-2022-0022</mixed-citation><mixed-citation xml:lang="en">Mohamed Noor N.F., Salleh M.Z., Mohd Zim M.A. et al. NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity. Pharmacogenomics. 2022;23(9):531-541. https://doi.org/10.2217/pgs-2022-0022</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vich Vila A., Hu S., Andreu-Sánchez S et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut. 2023;72(8):1472-1485. https://doi.org/10.1136/gutjnl-2022-328048</mixed-citation><mixed-citation xml:lang="en">Vich Vila A., Hu S., Andreu-Sánchez S et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut. 2023;72(8):1472-1485. https://doi.org/10.1136/gutjnl-2022-328048</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zou C., Mifflin L., Hu Z. et al. Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. Cell Reports. 2020;33(10):108447. https://doi.org/10.1016/j.celrep.2020.108447</mixed-citation><mixed-citation xml:lang="en">Zou C., Mifflin L., Hu Z. et al. Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. Cell Reports. 2020;33(10):108447. https://doi.org/10.1016/j.celrep.2020.108447</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu K., Xu A., Xia W. et al. Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2021;11:567762. https://doi.org/10.3389/fonc.2021.567762</mixed-citation><mixed-citation xml:lang="en">Zhu K., Xu A., Xia W. et al. Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2021;11:567762. https://doi.org/10.3389/fonc.2021.567762</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C.L., Liu Z.P., Guo L. NAT2 knockdown inhibits the development of colorectal cancer and its clinical significance. European Review for Medical and Pharmacological Sciences. 2021;25(9):3460-3469. https://doi.org/10.26355/eurrev_202105_25827</mixed-citation><mixed-citation xml:lang="en">Wang C.L., Liu Z.P., Guo L. NAT2 knockdown inhibits the development of colorectal cancer and its clinical significance. European Review for Medical and Pharmacological Sciences. 2021;25(9):3460-3469. https://doi.org/10.26355/eurrev_202105_25827</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Elsalem L., Al Shatnawi A., Alfaqih M. et al. Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk. Acta Biochimica Polonica. 2023;70(3):575-582. https://doi.org/10.18388/abp.2020_6590</mixed-citation><mixed-citation xml:lang="en">Elsalem L., Al Shatnawi A., Alfaqih M. et al. Discovery of a novel genetic variant in the N-acetyltransferase2 (NAT2) gene that is associated with bladder cancer risk. Acta Biochimica Polonica. 2023;70(3):575-582. https://doi.org/10.18388/abp.2020_6590</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J., Shao F., Zhang S., Qian Y., Chen M. A pan-cancer analysis of the oncogenic role of N-acetyltransferase 8 like in human cancer. Discover Oncology. 2024;15(1):792. https://doi.org/10.1007/s12672-024-01605-w</mixed-citation><mixed-citation xml:lang="en">Chen J., Shao F., Zhang S., Qian Y., Chen M. A pan-cancer analysis of the oncogenic role of N-acetyltransferase 8 like in human cancer. Discover Oncology. 2024;15(1):792. https://doi.org/10.1007/s12672-024-01605-w</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sirivarasai J., Chanprasertyothin S., Kongtip P., Woskie S. Genetic Polymorphisms of Pesticide-Metabolizing Enzymes and Transporters in Agricultural Workers and Thyroid Hormone Levels. Risk Management and Healthcare Policy. 2021;14:3435-3451. https://doi.org/10.2147/RMHP.S314510</mixed-citation><mixed-citation xml:lang="en">Sirivarasai J., Chanprasertyothin S., Kongtip P., Woskie S. Genetic Polymorphisms of Pesticide-Metabolizing Enzymes and Transporters in Agricultural Workers and Thyroid Hormone Levels. Risk Management and Healthcare Policy. 2021;14:3435-3451. https://doi.org/10.2147/RMHP.S314510</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gogolewska M., Kabziński J., Majsterek I. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population. International Journal of Occupational Medicine and Environmental Health. 2023;36(6):812-824. https://doi.org/10.13075/ijomeh.1896.02070</mixed-citation><mixed-citation xml:lang="en">Gogolewska M., Kabziński J., Majsterek I. Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population. International Journal of Occupational Medicine and Environmental Health. 2023;36(6):812-824. https://doi.org/10.13075/ijomeh.1896.02070</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wise J.T.F., Salazar-González R.A., Habil M.R. et al. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. Toxicology and Applide Pharmacology. 2022;442:115993. https://doi.org/10.1016/j.taap.2022.115993</mixed-citation><mixed-citation xml:lang="en">Wise J.T.F., Salazar-González R.A., Habil M.R. et al. Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. Toxicology and Applide Pharmacology. 2022;442:115993. https://doi.org/10.1016/j.taap.2022.115993</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hong K.U., Salazar-González R.A., Walls K.M., Hein D.W. Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines. Toxicological Sciences. 2022;190(2):158-172. https://doi.org/10.1093/toxsci/kfac103</mixed-citation><mixed-citation xml:lang="en">Hong K.U., Salazar-González R.A., Walls K.M., Hein D.W. Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines. Toxicological Sciences. 2022;190(2):158-172. https://doi.org/10.1093/toxsci/kfac103</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Carlisle S.M., Trainor P.J., Doll M.A., Hein D.W. Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2. Front Pharmacol. 2022;12:803254. https://doi.org/10.3389/fphar.2021.803254</mixed-citation><mixed-citation xml:lang="en">Carlisle S.M., Trainor P.J., Doll M.A., Hein D.W. Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2. Front Pharmacol. 2022;12:803254. https://doi.org/10.3389/fphar.2021.803254</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Walraven J.M., Zang Y., Trent J.O., Hein D.W. Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. Curr Drug Metab. 2008;9(6):471-486. https://doi.org/10.2174/138920008784892065</mixed-citation><mixed-citation xml:lang="en">Walraven J.M., Zang Y., Trent J.O., Hein D.W. Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. Curr Drug Metab. 2008;9(6):471-486. https://doi.org/10.2174/138920008784892065</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Перетолчина Н.П., Малов И.В., Семинский И.Ж. Роль полиморфизма гена N-ацетилтрансферазы 2 в патологии человека. Acta Biomedica Scientifica. 2021;6(5):30-43 [Peretolchina N.P., Malov I.V., Seminskiy I.Zh. Role of N-acetyltransferase 2 gene polymorphism in the human pathology. Acta Biomedica Scientifica. 2021;6(5):30-43 (In Russ.)]. https://doi.org/10.29413/ABS.2021-6.5.4</mixed-citation><mixed-citation xml:lang="en">Перетолчина Н.П., Малов И.В., Семинский И.Ж. Роль полиморфизма гена N-ацетилтрансферазы 2 в патологии человека. Acta Biomedica Scientifica. 2021;6(5):30-43 [Peretolchina N.P., Malov I.V., Seminskiy I.Zh. Role of N-acetyltransferase 2 gene polymorphism in the human pathology. Acta Biomedica Scientifica. 2021;6(5):30-43 (In Russ.)]. https://doi.org/10.29413/ABS.2021-6.5.4</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular &amp; Cellular Proteomics. 2014;13(2):397-406. https://doi.org/10.1074/mcp.M113.035600</mixed-citation><mixed-citation xml:lang="en">Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular &amp; Cellular Proteomics. 2014;13(2):397-406. https://doi.org/10.1074/mcp.M113.035600</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Guilhen A.C., Bufalo N.E., Morari E.C. et al. Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clinical cancer research. 2009;15(1):406-12. https://doi.org/10.1158/1078-0432.CCR-08-1835</mixed-citation><mixed-citation xml:lang="en">Guilhen A.C., Bufalo N.E., Morari E.C. et al. Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility. Clinical cancer research. 2009;15(1):406-12. https://doi.org/10.1158/1078-0432.CCR-08-1835</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Barbieri R.B., Bufalo N.E., Secolin R. et al. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. European Journal of Endocrinology. 2012;166(2):241-5. https://doi.org/10.1530/EJE-11-0843</mixed-citation><mixed-citation xml:lang="en">Barbieri R.B., Bufalo N.E., Secolin R. et al. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. European Journal of Endocrinology. 2012;166(2):241-5. https://doi.org/10.1530/EJE-11-0843</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Barbieri R.B., Bufalo N.E., Cunha L.L. et al. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. The Journal of Clinical Endocrinology &amp; Metabolism. 2013;79(2):288-93. https://doi.org/10.1111/cen.12136</mixed-citation><mixed-citation xml:lang="en">Barbieri R.B., Bufalo N.E., Cunha L.L. et al. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. The Journal of Clinical Endocrinology &amp; Metabolism. 2013;79(2):288-93. https://doi.org/10.1111/cen.12136</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
